1. Latest News
  2. Submit Press Release
Cambridge Healthtech Institute Logo

CHI to Hold its 2nd Mass Spectrometry in Clinical Diagnostics Conference, August 21-22, 2012, DC

This conference is part of the Next Generation Dx Summit: Moving Assays to the Clinic (Aug. 21-23).

May 11, 2012 - PRLog -- There have been over 50 papers published outlining the use of mass spec methods in clinical microbiology laboratories alone. It offers the advantage of greater sensitivity and specificity over other methods and has applications in infectious disease and oncology diagnostics. Cambridge Healthtech Institute (CHI) announces its 2nd Annual Mass Spectrometry in Diagnostics of Infectious Disease and Clinical Laboratory conference on August 21-22, 2012 at the Hyatt Regency Washington on Capitol Hill, Washington, DC. This conference is part of CHI’s Next Generation Dx Summit: Moving Assays to the Clinic. (August 21-23).

Sessions include:

- Applying Mass Spec-Based Methods to Infectious Disease
- Implementation of Mass Spectrometry in Clinical Microbiology

Plenary Keynote Session:

Regulation of LDTs and RUOs

Alberto Gutierrez, Ph.D., Deputy Director, Office of in vitro Diagnostic Device Evaluation and Safety, Food & Drug Administration
Moderated by: Franklin R. Cockerill, III, M.D., Ann and Leo Markin Professor of Microbiology & Medicine; Chair, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine; President and CEO, Mayo Medical Laboratories and Mayo Collaborative Services, Inc.

Plenary Keynote:

Position of IVDs on Regulatory Issues

Alan Mertz, President, American Clinical Laboratory Association (ACLA)

Diagnostic Manufacturers: Key Regulatory Issues

Andrew C. Fish, Executive Director, AdvaMedDx

Distinguished Speaker Faculty:

Robert Bonomo, M.D., Associate Professor of Medicine, Division of Infectious Disease and HIV Medicine, Case Western Reserve University

Richard R. Drake, Ph.D., Professor and Director, MUSC Proteomics Center, Medical University of South Carolina

Garth D. Ehrlich, Ph.D., Executive Director, Center for Genomic Sciences, Allegheny-Singer Research Institute

Daniel P. Fedorko, Ph.D., Microbiologist, NIH/CC/DLM/Microbiology Service

Mark Fisher, Ph.D., Assistant Professor of Pathology, The University of Utah, ARUP Institute for Clinical and Experimental Pathology

Christine C. Ginocchio, Ph.D., M.T. (ASCP), Chief, Division of Infectious Disease Diagnostics, Department of Pathology and Laboratory Medicine Professor, Hofstra University North Shore-LIJ School of Medicine North Shore-LIJ Health System Laboratories

Michael E. Hodsdon, M.D., Ph.D., Associate Professor of Laboratory Medicine and Pharmacology, Yale University School of Medicine

Anna F. Lau, Ph.D., Clinical Microbiology Fellow, Microbiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health

Nathan A. Ledeboer, Ph.D., Assistant Professor of Pathology, Medical College of Wisconsin

Scott McKeown, Ph.D, R&D Consultant, Randox Laboratories Ltd.

Javad Parvizi, M.D., FRCS, Vice Chairman, Research; Director, Clinical Research, Rothman Institute

Robin Patel, M.D., Chair, Division of Clinical Microbiology, Consultant, Divisions of Clinical Microbiology and Infectious Diseases, Professor of Microbiology and Medicine, College of Medicine, Mayo Clinic

Christopher Rath, Ph.D., Scientist, Dorrestein Laboratory, University of California, San Diego

Donna M. Wolk, M.H.A., Ph.D., D.(ABMM), Division Chief, Clinical and Molecular Microbiology; Associate Professor, Pathology and Medicine, Arizona Health Science Center and University Medical Center

As part of the Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Mass Spec for the Clinic), this event will bring together all of the major players in the evolving areas of diagnostics.

Those that register by June 1 will save up to $350.

To register and view the full agenda, visit http://www.NextGenerationDx.com/Mass-Spec-Clinical-Diagno...

To inquire about sponsorship/exhibit opportunities, contact Joseph Vacca at 781-972-5431, jvacca@healthtech.com.

Writers and editors are invited to attend.  To request a press pass, email tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and eCliniqua. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments.


James Prudhomme
Cambridge Healthtech Institute

--- End ---

Click to Share

Contact Email:
***@healthtech.com Email Verified
Source:Cambridge Healthtech Institute
Location:Needham - Massachusetts - United States
Industry:Biotech, Medical, Science
Tags:Mass Spec, Mass Spectrometry, Clinical Diagnostics, Fda, Molecular Diagnostics, Mass Spec Conference, Infectious Disease
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share